NL1021857A1 - Tamsulosinetabletten met een gewijzigde vrijgave. - Google Patents

Tamsulosinetabletten met een gewijzigde vrijgave.

Info

Publication number
NL1021857A1
NL1021857A1 NL1021857A NL1021857A NL1021857A1 NL 1021857 A1 NL1021857 A1 NL 1021857A1 NL 1021857 A NL1021857 A NL 1021857A NL 1021857 A NL1021857 A NL 1021857A NL 1021857 A1 NL1021857 A1 NL 1021857A1
Authority
NL
Netherlands
Prior art keywords
modified release
tamsulosin tablets
tamsulosin
tablets
release
Prior art date
Application number
NL1021857A
Other languages
English (en)
Other versions
NL1021857C2 (nl
Inventor
Jacobus Maria Lemmens
Johannes Jan Platteeuw
Frans Van Dalen
Arturo Siles Ortega
Juan Cucala Escoi
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23292437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1021857(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NL1021857A1 publication Critical patent/NL1021857A1/nl
Application granted granted Critical
Publication of NL1021857C2 publication Critical patent/NL1021857C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL1021857A 2001-11-07 2002-11-06 Tamsulosinetabletten met een gewijzigde vrijgave. NL1021857C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33105501P 2001-11-07 2001-11-07
US33105501 2001-11-07

Publications (2)

Publication Number Publication Date
NL1021857A1 true NL1021857A1 (nl) 2003-05-08
NL1021857C2 NL1021857C2 (nl) 2004-01-09

Family

ID=23292437

Family Applications (2)

Application Number Title Priority Date Filing Date
NL1021822A NL1021822C2 (nl) 2001-11-07 2002-11-01 Tamsulosinetabletten.
NL1021857A NL1021857C2 (nl) 2001-11-07 2002-11-06 Tamsulosinetabletten met een gewijzigde vrijgave.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL1021822A NL1021822C2 (nl) 2001-11-07 2002-11-01 Tamsulosinetabletten.

Country Status (21)

Country Link
US (2) US20030147950A1 (nl)
EP (3) EP1443917B1 (nl)
JP (3) JP2005512997A (nl)
CN (3) CN1298317C (nl)
AT (3) ATE321544T1 (nl)
AU (1) AU2002301845B2 (nl)
CA (2) CA2465110A1 (nl)
CZ (3) CZ16809U1 (nl)
DE (4) DE60210315T2 (nl)
DK (3) DK1443917T3 (nl)
ES (2) ES2256544T3 (nl)
HU (2) HUP0401978A3 (nl)
IL (4) IL161491A0 (nl)
NL (2) NL1021822C2 (nl)
NO (2) NO340960B1 (nl)
NZ (2) NZ532589A (nl)
PT (2) PT1443917E (nl)
RU (2) RU2311903C2 (nl)
SI (2) SI1443917T1 (nl)
WO (2) WO2003039530A1 (nl)
ZA (2) ZA200403281B (nl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE321544T1 (de) * 2001-11-07 2006-04-15 Synthon Bv Tamsulosin tabletten
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
IN192381B (nl) * 2002-12-20 2004-04-10 Ranbaxy Lab
US20040253309A1 (en) * 2003-01-27 2004-12-16 Yamanouchi Pharmaceutical Co., Ltd. Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
US20060147531A1 (en) * 2003-07-01 2006-07-06 Mojca Segula Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate
KR100762846B1 (ko) * 2003-09-29 2007-10-04 씨제이 주식회사 서방성 제제
WO2005030179A1 (en) * 2003-09-29 2005-04-07 Cj Corporation Sustained-release formulations
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
US8128958B2 (en) 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
WO2005053659A1 (en) * 2003-12-03 2005-06-16 Natco Pharma Limited An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
JP4603803B2 (ja) * 2004-01-30 2010-12-22 大洋薬品工業株式会社 放出制御医薬組成物およびこれを用いる製剤
PL204079B1 (pl) * 2004-08-12 2009-12-31 Inst Farmaceutyczny Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
KR100678421B1 (ko) * 2005-02-11 2007-02-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
KR101213345B1 (ko) * 2005-04-28 2012-12-17 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매약을 함유하는 조성물
CN1895241B (zh) * 2005-07-12 2010-05-12 可隆制药株式会社 盐酸坦洛新的口服长效性小药丸组成物及其制造方法
WO2007017253A1 (de) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung eines benzolsulfonamids
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
KR20070044911A (ko) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
EP2026766A1 (en) * 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) * 2007-06-26 2009-01-01 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (en) * 2007-09-26 2009-04-01 LEK Pharmaceuticals D.D. Controlled release tamsulosin hydrochloride tablets and a process of making them
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
US8920840B2 (en) 2010-04-30 2014-12-30 Takeda Pharmaceutical Company Limited Enteric tablet
CA2836865C (en) * 2011-05-25 2018-02-27 Taiho Pharmaceutical Co., Ltd. Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102579392A (zh) * 2012-03-30 2012-07-18 重庆科瑞制药(集团)有限公司 一种含有盐酸坦索罗辛的缓释制剂及其制备方法
WO2017186598A1 (en) 2016-04-25 2017-11-02 Synthon B.V. Modified release tablet composition comprising mirabegron
US10478399B2 (en) 2017-10-12 2019-11-19 Synthon B.V. Modified release tablet composition comprising mirabegron
EP3694492A1 (en) 2017-10-12 2020-08-19 Synthon B.V. Modified release tablet composition comprising mirabegron
EP3292864A1 (en) 2017-10-12 2018-03-14 Synthon B.V. Modified release tablet composition comprising mirabegron
WO2019076966A1 (en) 2017-10-17 2019-04-25 Synthon B.V. TABLETS COMPRISING TAMSULOSIN AND SOLIFENACIN

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
WO1994009785A2 (en) * 1992-11-04 1994-05-11 Sepracor, Inc. Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
AU7085194A (en) * 1993-07-14 1995-02-13 Yamanouchi Pharmaceutical Co., Ltd. Remedy for urination disorder accompanying prostatic hypertrophy
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
JP2001507359A (ja) * 1997-01-03 2001-06-05 エラン コーポレーション ピーエルシー 徐放性シサプリドミニ錠剤製剤
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (ja) * 1997-12-17 2009-02-12 興和創薬株式会社 テオフィリン徐放性錠剤及びその製造方法
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
JP2000080032A (ja) * 1998-06-26 2000-03-21 Yamanouchi Pharmaceut Co Ltd 排出障害治療剤
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1611881A1 (en) * 1999-03-31 2006-01-04 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
AU782059B2 (en) * 1999-05-20 2005-06-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
WO2001010436A1 (fr) * 1999-08-09 2001-02-15 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicinales destinees au traitement de l'uropathie inferieur
JP3154710B1 (ja) * 1999-08-09 2001-04-09 山之内製薬株式会社 下部尿路症治療剤
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
ES2351249T3 (es) * 2001-07-27 2011-02-02 Astellas Pharma Inc. Composición que comprende partículas finas, de liberación sostenida, para comprimidos de disgregación rápida en la cavidad bucal.
ATE321544T1 (de) * 2001-11-07 2006-04-15 Synthon Bv Tamsulosin tabletten

Also Published As

Publication number Publication date
IL161491A (en) 2009-07-20
WO2003039530A1 (en) 2003-05-15
US20030147955A1 (en) 2003-08-07
DE20221486U1 (de) 2006-02-02
SI1443917T1 (sl) 2006-06-30
ES2256544T3 (es) 2006-07-16
CN1652760A (zh) 2005-08-10
ZA200403281B (en) 2005-12-13
NL1021857C2 (nl) 2004-01-09
EP1595538A3 (en) 2006-02-22
EP1441713A1 (en) 2004-08-04
HUP0402004A3 (en) 2008-08-28
HUP0402004A2 (hu) 2005-01-28
SI1441713T2 (sl) 2019-03-29
CZ16813U1 (cs) 2006-08-28
JP2005512997A (ja) 2005-05-12
EP1595538A2 (en) 2005-11-16
US20030147950A1 (en) 2003-08-07
WO2003039531A1 (en) 2003-05-15
CN1298317C (zh) 2007-02-07
DE60221691T3 (de) 2019-04-04
ES2287333T3 (es) 2007-12-16
HUP0401978A2 (hu) 2005-01-28
CA2464689A1 (en) 2003-05-15
DE60221691T2 (de) 2008-04-30
RU2004117080A (ru) 2005-04-10
NZ532589A (en) 2005-02-25
ZA200403430B (en) 2006-02-22
HUP0401978A3 (en) 2008-07-28
RU2004117081A (ru) 2005-03-20
DE60210315D1 (de) 2006-05-18
DK1441713T4 (en) 2019-02-18
ES2287333T5 (es) 2019-04-29
EP1443917B1 (en) 2006-03-29
HU230830B1 (hu) 2018-07-30
AT9978U1 (de) 2008-07-15
DE60210315T2 (de) 2006-11-02
RU2335280C2 (ru) 2008-10-10
NO20042375L (no) 2004-08-09
CZ16809U1 (cs) 2006-08-28
JP5536610B2 (ja) 2014-07-02
PT1441713E (pt) 2007-08-28
CA2464689C (en) 2011-02-01
ATE321544T1 (de) 2006-04-15
DK1443917T3 (da) 2006-07-17
NO20042374L (no) 2004-08-09
NZ532592A (en) 2005-02-25
IL161525A (en) 2012-12-31
EP1443917A1 (en) 2004-08-11
JP2005511591A (ja) 2005-04-28
CA2465110A1 (en) 2003-05-15
NL1021822C2 (nl) 2003-07-15
RU2311903C2 (ru) 2007-12-10
CN102327250A (zh) 2012-01-25
PT1443917E (pt) 2006-06-30
DK1441713T3 (da) 2007-12-17
EP1441713B2 (en) 2018-11-14
CN1589139A (zh) 2005-03-02
DE60221691D1 (de) 2007-09-20
IL161491A0 (en) 2004-09-27
IL161525A0 (en) 2004-09-27
AU2002301845B2 (en) 2008-06-05
EP1441713B1 (en) 2007-08-08
CZ16814U1 (cs) 2006-08-28
DK200500297U3 (da) 2006-03-10
NO340960B1 (no) 2017-07-31
ATE369128T2 (de) 2007-08-15
DE20220415U1 (de) 2003-10-09
SI1441713T1 (sl) 2007-10-31
JP2011051995A (ja) 2011-03-17
NL1021822A1 (nl) 2003-05-08

Similar Documents

Publication Publication Date Title
NL1021857A1 (nl) Tamsulosinetabletten met een gewijzigde vrijgave.
ITTO20010166U1 (it) Giocattolo a trottola.
NO20041165L (no) Avstengningsanordning.
BR0313362B1 (pt) botço.
ITTO20030507A1 (it) Premistoppa a tenuta di fango.
FR2836907B1 (fr) Microvanne a actionnement pyrotechnique
ITMI20030127A1 (it) Piattaforma a morsetti azionata meccanicamente.
ITMI20032170A1 (it) Tagliacimosse.
ITNA20020053A1 (it) Leva rotorbitante.
NL1024812A1 (nl) Lampenkap.
BR8202023Y1 (pt) disposição introduzida em luminária.
ES1052590Y (es) Quiosco-consigna.
ES1048877Y (es) Tetilla para biberon.
ITRE20010008U1 (it) Perfezionamenti a variatori.
ES1052824Y (es) Central de emergencias.
ITMI20022640A1 (it) Dispositivo di raccordo rapido, a sicurezza migliorata,
ES1048472Y (es) Un asiento.
ES1050840Y (es) Un expositor poliedrico auto-armable.
ES1051603Y (es) Palillero automatico.
ITRE20030119A1 (it) Dispositivo luminoso a luce riflessa serigrafica.
ES1053421Y (es) Linterna.
ES1050774Y (es) Un cuadro-pecera
ES1052628Y (es) Extintor instantaneo.
FI20012551A0 (fi) Työntölaite
ES1051605Y (es) Cromo-puzzle.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20030513

PD2B A search report has been drawn up
RC Pledge established

Free format text: DETAILS LICENCE OR PLEDGE: RIGHT OF PLEDGE, ESTABLISHED

Name of requester: ARES MANAGEMENT LIMITED

Effective date: 20200310

MK Patent expired because of reaching the maximum lifetime of a patent

Effective date: 20221105